News

Gcore Enlists AI Pioneer Prof. Dr. Feiyu Xu as New Advisor

Gcore Enlists AI Pioneer Prof. Dr. Feiyu Xu as New Advisor

Gcore Welcomes AI Innovator to Board of Advisors

Gcore, a leading provider of edge AI, cloud, network, and security solutions, is excited to announce the appointment of Prof. Dr. Feiyu Xu as a member of its Board of Advisors. Prof. Dr. Xu is a prominent expert in the field of artificial intelligence (AI), bringing a wealth of experience from her past leadership roles at respected organizations such as SAP and Lenovo, as well as the German Research Centre for AI. Her significant contributions and insights into AI research will be invaluable as Gcore continues its mission to innovate in this essential sector.

Enhancing AI Innovation at Gcore

With Prof. Dr. Xu's arrival, Gcore aims to refine its AI strategy and long-term vision. Since its inception in 2014, Gcore has been on a path of continuous development, most recently launching a groundbreaking product called Everywhere Inference. This technology enables businesses to deploy AI solutions in versatile environments, such as cloud, on-premise, and hybrid settings. The deployment model allows for improved processing efficiency, resulting in quicker response times for users and applications.

The Role of AI in Modern Business

As businesses worldwide increasingly rely on AI to enhance efficiency and drive decision-making, Gcore stands at the forefront of this transformation. Today, the company supports a vast global infrastructure that spans six continents, making it possible for organizations to train and implement AI models with ultra-low latency. With over 180 edge locations and more than 50 cloud sites, Gcore is dedicated to bringing AI workloads as close to users as possible, ensuring a performance that is both rapid and cost-effective.

A Visionary Perspective

Prof. Dr. Xu expressed her enthusiasm about joining Gcore, stating, "I am thrilled to be joining as Gcore's Board Advisor, a unique tech company with immense potential. Gcore not only provides the infrastructure needed for developing AI applications, but it also actively contributes to the growth of the AI ecosystem. I am honored to be part of a team that will shape the future of technology and innovation." Her vision aligns perfectly with Gcore's commitment to leading the AI landscape.

Building a Future of Connectivity and AI

Gcore's Chief Executive Officer, Andre Reitenbach, remarked on the importance of Prof. Dr. Xu's appointment: "It is an honor to welcome Prof. Xu as Board Advisor. Her strategic vision and extensive expertise in AI will make her a valuable addition to our board. With her deep understanding of AI's potential, we are confident that she will play a pivotal role in advancing our goals to connect the world with AI solutions that are accessible anywhere at any time."

About Gcore

Gcore operates as a global edge AI, cloud, network, and security solutions provider, headquartered in Luxembourg. With a team of over 600 professionals working from ten offices around the globe, Gcore has managed to deliver cutting-edge solutions to industry leaders across various sectors. The company's global IT infrastructure is proven to perform exceptionally well, with an average response time of 30 ms globally. The network consists of more than 180 points of presence situated in Tier IV and Tier III data centers, with a total capacity that exceeds 200 Tbps.

Frequently Asked Questions

Who is Prof. Dr. Feiyu Xu?

Prof. Dr. Feiyu Xu is an acclaimed expert in AI, with extensive leadership experience in notable organizations.

What is Everywhere Inference?

Everywhere Inference is Gcore's innovative product that enables flexible deployment of AI applications in various environments.

How does Gcore support AI businesses?

Gcore provides a robust global infrastructure that facilitates the training and deployment of AI models with ultra-low latency.

What are Gcore's future plans?

Gcore aims to leverage Prof. Dr. Xu's expertise to enhance its AI strategy and product offerings, solidifying its leadership in the sector.

Where is Gcore headquartered?

Gcore is headquartered in Luxembourg, serving customers across the globe from multiple locations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading

Top 5 Most Recently Viewed Articles

FMC Corporation Transitions by Selling Global Specialty Solutions

Updated Category News Views 137

FMC Corporation Transitions by Selling Global Specialty Solutions FMC Corporation (NYSE: FMC), a prominent player in the agricultural sciences sector, has recently completed the sale of its Global Specialty Solutions business. This significant transaction marks a decisive shift in the company's focus to enhance its core operations and streamline its offerings in the...

Continue Reading
CG Oncology's Promising Future: Analysts Highlight Key Developments

Updated Category News Views 88

Analyst Coverage Boosts CG Oncology's Market Prospects Recently, CG Oncology (NASDAQ:CGON) garnered attention when UBS initiated coverage, assigning a Buy rating with an ambitious price target of $60.00. This endorsement underscores the potential of the company’s flagship program, cretostimogene (creto), which targets non-muscle invasive bladder cancer (NMIBC). Positive...

Continue Reading
Current Trends in Cryptocurrency Market: Key Insights

Updated Category News Views 386

Bearish Pressures on Major Cryptocurrencies In recent days, cryptocurrencies have faced significant bearish trends, with only XRP showing some resilience. This decline raises important questions for traders and investors navigating the volatile crypto landscape. Market Overview: Key Cryptocurrency Prices Here are the current prices and performance metrics for the leading...

Continue Reading
Enhanced Cancer Guidelines Include Key Insights on LEMS

Updated Category News Views 146

Updated Guidelines for LEMS and SCLC In a significant advancement, the National Comprehensive Cancer Network (NCCN) has included essential recommendations for Lambert Eaton Myasthenic Syndrome (LEMS) in their Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC). Importance of VGCC Antibody Testing The updated guidelines emphasize the crucial role of VGCC...

Continue Reading
VEON Invests in Ukraine: Commitment to Digital Growth

Updated Category News Views 102

VEON's Commitment to Investing in Ukraine VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has recently made significant news with its promise to enhance Ukraine’s telecommunications infrastructure. In collaboration with its fully-owned subsidiary, Kyivstar, VEON participated in the 2024 Yalta European Strategy (YES) Annual Meeting. At this event, the focus...

Continue Reading